Dalrada adds Dr. David Bacon to its Board of Directors

– USA, CA –  Dalrada Corporation (OTC: DFCO) today announced the appointment of Dr. David Bacon Ph.D. to its Board of Directors.

“We are thrilled that Dr. Bacon has accepted a role with Dalrada’s Board of Directors. His extensive background of conducting, directing, and developing evidence-based research will be extremely valuable insight for accelerated availability of Dalrada Health’s product lines.” said CEO, Brian Bonar.

The Board of Directors is now composed of:

  • Brian Bonar, Dalrada Founder & CEO – Technology & Engineering
  • Tom Giles – Technology & Clean Energy
  • Pauline Gourdie – Supply Chain & Recruitment
  • Harvey Herskowitz – Healthcare & Technology
  • Brian Kendrick – Aviation & Acquisitions
  • Fawad Nisar – Operations, Science & Engineering
  • Fletcher Robbe – Legal & Finance
  • Anthony Zolezzi – Sustainability & Technology

About Dr. David Bacon

Dr. Bacon is an active Navy CAPTAIN with 22 years of active duty service. During the SARS-CoV-2 pandemic, Dr. Bacon was responsible for reviewing proposals for funding in the areas of therapeutics, diagnostics, and wearable monitors. He reviewed more than 400 proposals and provided his expert opinion on the scientific rationale and study design.

Dr. Bacon’s professional background includes:

  • Former program Area Manager, DoD’s HIV and Emerging Infectious Diseases research programs
  • Science and Technology Program management/program development, Chemistry Division, Naval Research Laboratory
  • Deployed as Officer-in-Charge, Forward Deployed Preventive Medicine, Kandahar Airfield, Afghanistan and Camp Arifjan, Kuwait
  • Deployed as sole microbiologist aboard USNS Comfort in support of Continuing Promise 2009
  • Head, Laboratory Sciences, Navy Environmental and Preventive Medicine Unit 2, Norfolk, VA
  • Director, Parasitology Program, Naval Medical Research Unit 6 (NAMRU-6), Lima, Peru
  • Deputy Director, Parasitology Department, NAMRU-6, Lima, Peru
  • Member of scientific assessment team commissioned by the Iraq Survey Group to investigate biological weapons programs in Baghdad, Iraq
  • Deployed as element commander of a biological weapons detection laboratory, Baghdad, Iraq
  • Principal Investigator, Malaria Program Naval Medical Research Center, Research Area: Proteomics and functional genomics of Plasmodium sp.
  • Postdoctoral Fellow, Naval Medical Research Center

Dr. Bacon has published 35 peer-reviewed manuscripts and has been invited to give seminars and lead health-related discussions with MoH/DoD officials worldwide to include Thailand, Cambodia, Vietnam, India, Indonesia, and Singapore. Dr. Bacon received his Ph.D. in Microbiology from the University of New Hampshire in 1997, is certified as a level III Science and Technology Manager, and is a member of the global health specialist program.

About Dalrada

Dalrada Corporation solves complex global problems by producing innovation-focused and technologically centered solutions. Delivering next-generation manufacturing, engineering, healthcare, and technology products and services designed to propel growth, Dalrada is a team of industry experts and an organization built upon a strong foundation of capital management. The Company and its subsidiaries are positioned for stable long-term growth through intelligent market research, sound business acumen, and established operational infrastructure.

For more information : https://dalrada.com/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.